UW–Madison Plans $62 Million Cyclotron Laboratory Expansion
UW-Madison is expanding its cyclotron laboratory with a $62 million project that will focus on developing and exploring promising cancer treatments. The expansion includes adding the nation's first alpha-particle cyclotron to enhance the production of radionuclides for diagnosing and treating…
Green Bay Appleton, WI, October 22, 2026 —
The University of Wisconsin–Madison is expanding its cyclotron laboratory through a $62 million project focused on developing and exploring cancer treatments, according to the information provided about the project.
A central part of the expansion is the addition of what the summary describes as the nation’s first alpha-particle cyclotron. The equipment is intended to enhance production of radionuclides, which the project summary says can be used in diagnosing and treating various cancers.
The project links the laboratory expansion with research into potential cancer treatments and the production of materials for cancer diagnosis and care. The summary does not identify specific cancers, treatments, or radionuclides involved, and it does not describe how the new cyclotron will be operated or what research projects will use it.
Details about the project’s schedule, construction plans, funding breakdown, and expected completion date were not provided. The information also does not name project leaders or include statements from university representatives. No additional details were available about how the expansion may affect patients or when any treatments developed through the work could become available.
For now, the stated scope is a $62 million laboratory expansion and the addition of an alpha-particle cyclotron to support radionuclide production for cancer diagnosis and treatment. Further information about the timeline and the research planned for the expanded facility was not included in the summary.
Story summarized from the original created by Elissa Eaton on www.wpr.org, see more information here.
